Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial"

Comment

Bertrand Trilling et al. Ann Surg. 2021.

. 2021 Dec 1;274(6):e788-e789.

doi: 10.1097/SLA.0000000000004403.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest.

Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial.
Gao Z, Wang C, Cui Y, Shen Z, Jiang K, Shen D, Wang Y, Zhan S, Guo P, Yang X, Liu F, Shen K, Liang B, Yin M, Xie Q, Wang Y, Wang S, Ye Y. Gao Z, et al. Ann Surg. 2020 Mar;271(3):519-526. doi: 10.1097/SLA.0000000000003012. Ann Surg. 2020. PMID: 30148752 Clinical Trial.

1. Gao Z, Wang C, Cui Y, et al. Efficacy and safety of complete mesocolic excision in patients with colon cancer - three-year results from a prospective, nonrandomized, double-blind, controlled trial. Ann Surg 2020; 271:519–526.
1. Hohenberger W, Weber K, Matzel K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation—technical notes and outcome. Colorectal Dis 2009; 11:354–364.
1. Merkel S, Weber K, Matzel KE, et al. Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision. Br J Surg 2016; 103:1220–1229.
1. Wang C, Gao Z, Shen K, et al. Safety, quality and effect of complete mesocolic excision vs non-complete mesocolic excision in patients with colon cancer: a systemic review and meta-analysis. Colorectal Dis 2017; 19:962–972.
1. Bertelsen CA, Neuenschwander AU, Jansen JE, et al. 5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort study. Lancet Oncol 2019; 20:1556–1565.